Sane Pharma Private Limited
About Sane Pharma Private Limited
Data last updated:
Sane Pharma Private Limited is a private limited company based in Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 18 June 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2008PTC179715. Its GSTIN is 10AANCS3152M1ZA (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Samant Kumar and Rashmi Bala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.141/42 Flat No.T – 3 Street No.4 Guru Ram Das Nagar Laxmi Nagar Delhi – 1, 10092, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹25.65 Lakh, a decline of 26% compared to the previous year. For the same year it recorded a net profit of ₹53,849 (net margin 2.1%) and EBITDA of ₹1.09 Lakh (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 108% over three years and 19% over five years.
As per MCA filings, the company has open charges of ₹5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No.141/42 Flat No.T – 3 Street No.4 Guru Ram Das Nagar Laxmi Nagar Delhi – 1, 10092, Delhi, India – 110092
- IndustryTrading, Other Wholesale, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Sane Pharma Private Limited
The main business activity of Sane Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sane Pharma Private Limited FY 2025 filings available
Sane Pharma Private Limited reported revenue of ₹25.65 Lakh (down 26% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Sane Pharma Private Limited
Revenue fell 26% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 19%. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sane Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.09 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹53,849 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sane Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sane Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Sane Pharma Private Limited
Sane Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samant Kumar | Director | 18 Jun 2008 | 18 Years 4 Months | Current |
| Rashmi Bala Also directs: Eesse Life Science LLP | Director | 25 Feb 2019 | 7 Years 7 Months | Current |
Peer Comparison of Sane Pharma Private Limited
Sane Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Praelatus Products Private Limited | ₹25.65 Lakh (FY 2025) | •••• | •••• | -41.0% | •••• | New Delhi, Delhi, India |
| Shree Sant Namdev Shetkari Farmers Producer Company Limited | ₹25.65 Lakh (FY 2024) | •••• | •••• | 256.0% | •••• | Hingoli, Maharashtra, India |
| Alif Lifecare Private Limited | ₹25.65 Lakh (FY 2022) | •••• | •••• | 69.0% | •••• | Moradabad, Uttar Pradesh, India |
| Babo Services Private Limited | ₹25.65 Lakh (FY 2024) | •••• | •••• | •••• | Ahmedaabad, Gujarat, India | |
| Sunil Alloys & Steels Limited | ₹25.65 Lakh (FY 2020) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Sane Pharma Private Limited this company | ₹25.65 Lakh (FY 2024) | •••• | •••• | -26.0% | •••• | Delhi, India |
| Baneswar Krishak Bondhu Farmers Producer Company Limited | ₹25.64 Lakh (FY 2025) | •••• | •••• | 38.0% | •••• | Cooch Behar, West Bengal, India |
| Diasha Life Sciences Private Limited | ₹25.64 Lakh (FY 2024) | •••• | •••• | 50.0% | •••• | Nagole, Telangana, India |
| Agarwal Brothers Tradex Private Limited | ₹25.64 Lakh (FY 2016) | •••• | •••• | -93.0% | •••• | Delhi, India |
| Rockon Capital Market Private Limited | ₹25.64 Lakh (FY 2019) | •••• | •••• | -65.0% | •••• | Mumbai, Maharashtra, India |
| Supreme Autotech Industries Private Limited | ₹25.63 Lakh (FY 2024) | •••• | •••• | -46.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Sane Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Sane Pharma Private Limited
Sane Pharma Private Limited is audited by ALOK JAIN & CO. for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ALOK JAIN & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Sane Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sane Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 May 2016 | Others | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Sane Pharma Private Limited
Employment history and EPFO contributions of people linked to Sane Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sane Pharma Private Limited
Sane Pharma Private Limited has 6 board changes on record since 2008: 2 appointments and 4 cessations. The latest: Kumar Saurabh ceased to be Director on 22 Mar 2021.
Credit Ratings, Litigation & Regulatory Alerts for Sane Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sane Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sane Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sane Pharma Private Limited
Sane Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AANCS3152M1ZA | Bihar | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sane Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sane Pharma Private Limited
Sane Pharma is an active private limited company based in Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 18 June 2008 (18+ years old) and is registered under CIN U24232DL2008PTC179715.
Sane Pharma reported revenue of ₹25.65 Lakh for FY 2024 (down 26% YoY).
Sane Pharma has 2 current directors:
- Samant Kumar - Director
- Rashmi Bala - Director
Sane Pharma reported a net profit of ₹53,849 (net margin 2.1%) and EBITDA of ₹1.09 Lakh (EBITDA margin 4.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sane Pharma is 108% over three years and 19% over five years. In the latest year (FY 2024) revenue fell 26%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sane Pharma is 10AANCS3152M1ZA, registered in Bihar.
The CIN (Corporate Identification Number) of Sane Pharma is U24232DL2008PTC179715. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sane Pharma was incorporated on 18 June 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Sane Pharma by revenue are Praelatus Products Private Limited, Shree Sant Namdev Shetkari Farmers Producer Company Limited, Alif Lifecare Private Limited, Babo Services Private Limited, Sunil Alloys & Steels Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Kumar Saurabh ceased to be Director on 22 Mar 2021. Sanjay Kumar Singh ceased to be Director on 27 Feb 2019. Sanjeet Kumar Singh ceased to be Director on 27 Feb 2019. Sane Pharma has 6 board changes on record in total.
The registered office of Sane Pharma is at Plot No.14142 Flat No.T – 3 Street No.4 Guru Ram Das Nagar Laxmi Nagar Delhi – 1, 10092, Delhi, India – 110092.